Galliford Try Plc (GFRD):企業の財務・戦略的SWOT分析

◆英語タイトル:Galliford Try Plc (GFRD) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C12655
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:53
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:建設・建築
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Galliford Try Plc (GFRD) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Galliford Try plc (Galliford Try) is a housebuilding, regeneration and construction company. It offers construction and housebuilding services under various brands, Galliford Try brand, Linden Homes, Galliford Try Partnerships, Morrison Construction, Oak Dry Lining, Rock & Alluvium, and Drew Smith. The company caters its services to various sectors including education, health, leisure, commercial and housing, water, highways, rail, remediation, flood alleviation and renewable energy sectors. Galliford Try undertakes major building and infrastructure projects through public-private partnerships. In addition, it provides and manages a comprehensive range of facility management and maintenance services for various organizations in the public and private sectors. Galliford Try is headquartered in Uxbridge, England, the UK.

Galliford Try Plc Key Recent Developments

Nov 12,2018: Nick Culshaw joins from asphalt contractor Volker Stevin
Nov 09,2018: Galliford Try appointed to 8bn Highways England framework 09 Nov 2018
Nov 09,2018: Galliford Try appointed to 8bn Highways England framework 09 Nov 2018
Nov 07,2018: Galliford Try suffers fresh 20m Aberdeen bypass hit
Oct 05,2018: Galliford Try operations manager pilots RAF project to success

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Galliford Try Plc – Key Facts 5
Galliford Try Plc – Key Employees 6
Galliford Try Plc – Key Employee Biographies 7
Galliford Try Plc – Major Products and Services 8
Galliford Try Plc – History 9
Galliford Try Plc – Company Statement 16
Galliford Try Plc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Section 2 – Company Analysis 22
Company Overview 22
Galliford Try Plc – Business Description 23
Galliford Try Plc – Corporate Strategy 24
Galliford Try Plc – SWOT Analysis 25
SWOT Analysis – Overview 25
Galliford Try Plc – Strengths 25
Galliford Try Plc – Weaknesses 26
Galliford Try Plc – Opportunities 27
Galliford Try Plc – Threats 28
Galliford Try Plc – Key Competitors 29
Section 3 – Company Financial Ratios 30
Financial Ratios – Capital Market Ratios 30
Financial Ratios – Annual Ratios 31
Performance Chart 34
Financial Performance 34
Financial Ratios – Interim Ratios 35
Financial Ratios – Ratio Charts 36
Section 4 – Company’s Recent Developments 37
Nov 09, 2018: Galliford Try appointed to 8bn Highways England framework 09 Nov 2018 37
Sep 04, 2018: TOPC : OTC Markets Group Welcomes Artis Real Estate Investment Trust to OTCQX[Newswire : CRE - PRN] 39
Jul 13, 2018: Galliford Try claims Residential Developer of the Year and Project of the Year at CN Awards 41
Jul 09, 2018: Galliford Try: Double success for North Wales police project 42
May 08, 2018: Galliford Try claims 28 winners at CCS National awards 43
May 03, 2018: Royal Birmingham Conservatoire is named RICS ‘West Midlands’ Project of the Year 44
Apr 18, 2018: Keithhall Road reopened ahead of schedule after installation of new sewer pipeline 45
Feb 14, 2018: Galliford Try Half Year Report for the Six Months to 31 December 2017 46
Nov 24, 2017: Galliford Try wins two awards at Inside Housing Awards 47
Nov 10, 2017: Double win for Galliford Try Partnerships at LABC Grand Finals 48
Section 5 – Appendix 49
Methodology 49
Ratio Definitions 49
About GlobalData 53
Contact Us 53
Disclaimer 53

List of Tables
Galliford Try Plc, Key Facts 5
Galliford Try Plc, Key Employees 6
Galliford Try Plc, Key Employee Biographies 7
Galliford Try Plc, Major Products and Services 8
Galliford Try Plc, History 9
Galliford Try Plc, Other Locations 19
Galliford Try Plc, Subsidiaries 20
Galliford Try Plc, Key Competitors 29
Galliford Try Plc, Ratios based on current share price 30
Galliford Try Plc, Annual Ratios 31
Galliford Try Plc, Annual Ratios (Cont...1) 32
Galliford Try Plc, Annual Ratios (Cont...2) 33
Galliford Try Plc, Interim Ratios 35
Currency Codes 49
Capital Market Ratios 49
Equity Ratios 50
Profitability Ratios 50
Cost Ratios 51
Liquidity Ratios 51
Leverage Ratios 52
Efficiency Ratios 52

List of Figures
Galliford Try Plc, Performance Chart (2014 - 2018) 34
Galliford Try Plc, Ratio Charts 36

★海外企業調査レポート[Galliford Try Plc (GFRD):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CVRx Inc:医療機器:M&Aディール及び事業提携情報
    Summary CVRx Inc (CVRx) is a medical device company that develops and designs implantable device. The company provides barostim neo system, which is designed to trigger the body’s natural blood flow regulation system to treat high blood pressure and heart failure. Its products are used in the treatm …
  • The Chugoku Bank Ltd:企業の戦略・SWOT・財務情報
    The Chugoku Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary The Chugoku Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Invenergy LLC:企業の発電所・SWOT分析2018
    Invenergy LLC - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exec …
  • A&D Company Ltd (7745):企業の財務・戦略的SWOT分析
    Summary A&D Company Ltd (A&D Company) is a medical equipment company that manufactures, designs, develops, and distributes advanced measuring, controlling, monitoring, and testing instruments. The company’s products include powertrain testing systems, digital analog converter, DSP platform, model ba …
  • Aurinia Pharmaceuticals Inc (AUP):製薬・医療:M&Aディール及び事業提携情報
    Summary Aurinia Pharmaceuticals Inc (Aurinia Pharmaceuticals), formerly Isotechnika Pharma Inc, is a clinical stage biopharmaceutical company which develops and commercializes therapies for the treatment of debilitating diseases. Voclosporin, the company’s product candidate under clinical developmen …
  • Nippon Shikizai Inc.:企業の戦略・SWOT・財務情報
    Nippon Shikizai Inc. - Strategy, SWOT and Corporate Finance Report Summary Nippon Shikizai Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Delphi Automotive Plc (APTV):企業の財務・戦略的SWOT分析
    Delphi Automotive Plc (APTV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Kosmos Energy Ltd (KOS):石油・ガス:M&Aディール及び事業提携情報
    Summary Kosmos Energy Ltd. (Kosmos) is an independent oil and gas exploration and production company. Its primary areas of operation are frontier and emerging areas along the Atlantic Margin. The company’s asset portfolio includes existing production and development projects offshore Ghana, discover …
  • Smrt Corporation Ltd.:企業の戦略・SWOT・財務分析
    Smrt Corporation Ltd. - Strategy, SWOT and Corporate Finance Report Summary Smrt Corporation Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • The New York Times Company:企業の戦略・SWOT・財務情報
    The New York Times Company - Strategy, SWOT and Corporate Finance Report Summary The New York Times Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Miltenyi Biotec GmbH-医療機器分野:企業M&A・提携分析
    Summary Miltenyi Biotec GmbH (Miltenyi) is a biotechnology company which provides biomedical research and cellular therapy products for cell isolation, flow cytometry, sample preparation and cell culture. The company's services include sample preparation, cell separation, flow cytometry, cell cultur …
  • PT Pembangkitan Jawa-Bali:企業の戦略的SWOT分析
    PT Pembangkitan Jawa-Bali - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Kuraray Co., Ltd.:企業の戦略・SWOT・財務情報
    Kuraray Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kuraray Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • United Therapeutics Corp (UTHR):企業の財務・戦略的SWOT分析
    United Therapeutics Corp (UTHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Iovance Biotherapeutics Inc (IOVA):企業の財務・戦略的SWOT分析
    Iovance Biotherapeutics Inc (IOVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Integra Holdings Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Integra Holdings Ltd (Integra Holdings), a subsidiary of Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, is a healthcare investment company that invests in biopharmaceutical companies with products in clinical and pre-clinical stages of development. The company …
  • Phillips 66 Co (PSX):企業の財務・戦略的SWOT分析
    Phillips 66 Co (PSX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • New China Life Insurance Company Ltd.:戦略・SWOT・企業財務分析
    New China Life Insurance Company Ltd. - Strategy, SWOT and Corporate Finance Report Summary New China Life Insurance Company Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Zimmer Biomet Holdings Inc (ZBH):企業の財務・戦略的SWOT分析
    Zimmer Biomet Holdings Inc (ZBH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Pearson plc:企業の戦略・SWOT・財務情報
    Pearson plc - Strategy, SWOT and Corporate Finance Report Summary Pearson plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆